Biocytogen Launches "Nano 100 Project" to Develop Fully Human Nanobody Therapeutics for Over 100 Targets2
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) today announced the launch of the “Nano 100 Project”, which aims to develop fully human nanobody drugs for over 100 targets.
Source: businesswireindia.com